Cadila Healthcare Limited Budesonide Export Data — India (DGFT 2022–2026)

Name: Cadila Healthcare Limited Budesonide Export Records India — #8 Exporter, 22 Shipments, $787.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Budesonide

India Pharmaceutical Trade Intelligence

$190.5M275 Suppliers115 CountriesHS 30049099

ExportsIndia → UNITED STATES55.0%India → SAUDI ARABIA15.2%

ImportsITALY → India$229.2M SWEDEN → India$74.5M

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Cadila Healthcare Limited — Budesonide Exporter #8 | $787.7K Trade Value | TransData Nexus | TransData Nexus

Cadila Healthcare Limited — Budesonide Exporter Profile

Indian Pharmaceutical Exporter · #8 for Budesonide · $787.7K export value · DGFT Verified

Cadila Healthcare Limited is the #8 Indian exporter of Budesonide with $787.7K in export value and 22 verified shipments. Cadila Healthcare Limited holds a 0.4% market share in Budesonide exports across 5 countries. The company exports 41 pharmaceutical products worth $34.9M across 17 therapeutic categories.

Cadila Healthcare Limited — Budesonide Export Profile: Buyers & Destinations

Cadila Healthcare Limited Budesonide export treemap — buyers and destination countries | TransData Nexus

Where Does Cadila Healthcare Limited Export Budesonide?

Country	Value	Shipments	Share
UNITED STATES	$250.0K	5	40.6%
SRI LANKA	$211.3K	24	34.3%
VIETNAM	$119.2K	4	19.4%
KENYA	$18.9K	2	3.1%
SUDAN

Who Are the Top Buyers of Budesonide from Cadila Healthcare Limited?

Buyer	Country	Value	Orders
SUNSHINE HEALTHCARE LANKA LIMITED	SRI LANKA	$194.8K	21
NORTHSTAR HEALTHCARE UNLIMITED COMP	UNITED STATES	$150.0K	3
ZYDUS PHARMACEUTICALS USA INC	UNITED STATES	$100.0K	2
HAPHARCO J S C BRANCH	VIETNAM	$69.2K	3
HAPHARCOJ S CBRANCH	VIETNAM	$50.0K	1
GALAXY PHARMACEUTICAL LIMITED	KENYA	$18.9K	2
SUNSHINE HEALTHCARE LANKA LTD	SRI LANKA	$16.5K	3
M PHARMA CO LTD	SUDAN	$9.6K	1
FTM MAURITIUS LTD	MAURITIUS	$5.8K	2
FTM MAURITIUS LIMITED	MAURITIUS	$976	1

Cadila Healthcare Limited supplies Budesonide to 10 buyers globally. The largest buyer is SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA), followed by NORTHSTAR HEALTHCARE UNLIMITED COMP (UNITED STATES) and ZYDUS PHARMACEUTICALS USA INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Budesonide Formulations Does Cadila Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
BUDESONIDE ENTERIC COATED CAPSULE 3 MG -	$250.0K	5
FORMONIDE 400 MDI 1'S- HFAFORMOTEROL FUMARATE & BUDESONIDE INHALATION1 X 1 UNIT	$80.5K	7
FORMONIDE 400 RESPICAPS BUDESONIDE AND	$75.4K	5
FORMONIDE 200 INHALER BUDESONIDE & FORM	$75.1K	4
FORMONIDE 200 INHALERBUDESONIDE & FORMOTEROL FUMARATE INHALER1X120MDI	$50.0K	1
FORMONIDE 200 RESPICAPSBUDESONIDE AND FORMOTEROL FUMARATE RESPICAP3X10	$22.2K	6
FORMONIDE 400 RESPICAPSBUDESONIDE AND F	$16.5K	3
FORMONIDE 200 MDI 1'S- HFAFORMOTEROL FUMARATE & BUDESONIDE INHALATION1 X 1 UNIT	$13.5K	2
FORMONIDE 400 INHALER BUDESONIDE & FORMOTEROL FUMARATE INHALER 1X120MDI	$13.1K	1
FORMONIDE200HFA INHCFC FREE120MDIBUDESONIDE & FORMOTEROL FUMARATE INHALER1X 120 MD	$9.6K	1

Cadila Healthcare Limited exports 14 distinct Budesonide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BUDESONIDE ENTERIC COATED CAPSULE 3 MG - with 5 shipments worth $250.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Cadila Healthcare Limited Compare to Nearest Budesonide Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	AHLCON PARENTERALS INDIA LIMITED	$1.1M	22	2	$49.2K
6	AXA PARENTERALS LIMITED	$1.0M	43	9	$23.6K
8	CADILA HEALTHCARE LIMITED ★	$787.7K	22	5	$35.8K
7	MEDISPRAY LABORATORIES PRIVATE LIMITED	$600.0K	12	1	$50.0K
9	ALTHEA PHARMA PRIVATE LIMITED	$578.6K	119	1	$4.9K

Cadila Healthcare Limited ranks #8 among 275 Indian Budesonide exporters. Average shipment value of $35.8K compared to the market average of $256.7K. The closest competitors by value are AHLCON PARENTERALS INDIA LIMITED and AXA PARENTERALS LIMITED.

Which Indian Ports Ship Budesonide Exports?

Port	Shipments	% Share
SAHAR AIR	1,990	21.8%
DELHI AIR CARGO ACC (INDEL4)	1,616	17.7%
DELHI AIR	1,404	15.4%
SAHAR AIR CARGO ACC (INBOM4)	1,213	13.3%
Delhi Air	419	4.6%
Bombay Air	386	4.2%
NHAVA SHEVA SEA (INNSA1)	303	3.3%
Delhi Air Cargo	152	1.7%

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Budesonide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zydus. The escalating conflict in the Middle East has disrupted key maritime routes, particularly the Red Sea and Suez Canal, leading to longer transit times and increased freight costs. Major carriers have suspended or restricted transits, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes. (livemint.com) This situation poses significant challenges for time-sensitive pharmaceutical shipments, especially temperature-sensitive medicines. (economictimes.indiatimes.com)

Conversely, U.S.–China trade tensions have prompted the U.S. to impose tariffs on Chinese pharmaceutical imports, creating an opportunity for Indian exporters to fill the supply gap. However, the U.S. has also introduced tariffs on Indian imports, including a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) While pharmaceuticals are currently exempt, the potential for future tariffs necessitates strategic planning.

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial. The FMD mandates stringent serialization and traceability requirements to prevent counterfeit medicines from entering the supply chain. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU Good Manufacturing Practice (GMP) guidelines set stringent quality benchmarks. Any lapses can lead to import alerts, product recalls, or facility shutdowns. For instance, in 2019, Zydus's Moraiya facility received an Official Action Indicated (OAI) classification from the U.S. FDA, indicating that regulatory and/or administrative actions were recommended. (moneycontrol.com) Such events underscore the importance of robust quality assurance systems.

The evolving regulatory landscape demands continuous investment in compliance infrastructure. The EU's Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act (DSCSA) require advanced serialization and traceability measures. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Budesonide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cadila Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 39 individual customs records matching Cadila Healthcare Limited exporting Budesonide, covering 14 formulations to 6 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 609+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Budesonide

Budesonide

Cadila Healthcare Limited — Budesonide Exporter Profile

Cadila Healthcare Limited — Budesonide Export Profile: Buyers & Destinations

Where Does Cadila Healthcare Limited Export Budesonide?

Who Are the Top Buyers of Budesonide from Cadila Healthcare Limited?

What Is India's Total Budesonide Export Value and How Much Does Cadila Healthcare Limited Contribute?

What Is the Average Shipment Value for Cadila Healthcare Limited's Budesonide Exports?

How Does Cadila Healthcare Limited Compare to Other Indian Budesonide Exporters?

What Budesonide Formulations Does Cadila Healthcare Limited Export?

Regulatory Requirements: Exporting Budesonide to Key Markets

United States — FDA

How Does Cadila Healthcare Limited Compare to Nearest Budesonide Exporters?

Which Indian Ports Ship Budesonide Exports?

What Other Respiratory Products Does Cadila Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Budesonide Exports

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

About Cadila Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Budesonide Export Data from Cadila Healthcare Limited

Budesonide Stats

Company Overview

Top Products by Cadila Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source